Filing Details

Accession Number:
0000899243-21-035684
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-13 16:37:00
Reporting Period:
2021-09-09
Accepted Time:
2021-09-13 16:37:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1783328 Tscan Therapeutics Inc. TCRX Biological Products, (No Disgnostic Substances) (2836) 825282075
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1860597 M. Brian Silver C/o Tscan Therapeutics, Inc.
830 Winter Street
Waltham MA 02451
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Stock Acquisiton 2021-09-09 5,885 $8.48 6,885 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $8.34 to $8.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.